Symbol
CTMX on Nasdaq
Investment type
Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Shares Owned
4,068,575 shares
Security Ownership %
2.5%
Shares, Excluding Options vs Price
Value, Excluding Options

Point72 Asset Management, L.P. ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

14 Nov 2025 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,068,575 shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 2.5% ownership of the company. In their previous filing dated 14 Aug 2025, Point72 Asset Management, L.P. had reported owning 8,084,623 shares, indicating a decrease of +50%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.